Absolute lymphocyte count (ALC) is a predictor of eribulin benefit in advanced or metastatic breast cancer (MBC)

被引：0
|
作者：
Cortes, Javier [1 ,2 ]
Manuel Perez-Garcia, Jose [3 ]
Nomoto, Kenichi [4 ]
Alexis, Karenza [4 ]
Saito, Kenichi [5 ]
Yoshimura, Yuta [5 ]
Muramoto, Kenzo [5 ]
Miyoshi, Yasuo [6 ]
机构：
[1] IOB Inst Oncol, Quironsalud Grp, Barcelona, Spain
[2] Vall Hebron Inst Oncol, Barcelona, Spain
[3] IOB Inst Oncol, Quiron Grp, Quiron Univ Hosp, Barcelona, Spain
[4] Eisai Inc, Woodcliff Lake, NJ USA
[5] Eisai & Co Ltd, Tokyo, Japan
[6] Hyogo Coll Med, Nishinomiya, Hyogo, Japan
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P4-10-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-10-08
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Survival benefit of eribulin for metastatic breast cancer depends on absolute lymphocyte count and neutrophil-lymphocyte ratio in peripheral blood
    Ueno, Ayako
    Ohtani, Shoichiro
    Kawasaki, Kensuke
    Ito, Mitsuya
    Kin, Takanori
    Maeda, Reina
    CANCER RESEARCH, 2020, 80 (04)
  • [2] Impact of absolute lymphocyte count on the efficacy of eribulin and capecitabine in patients with metastatic breast cancer.
    Ueno, Ayako
    Maeda, Reina
    Kim, Kyeongduk
    Ito, Mitsuya
    Kawasaki, Kensuke
    Ohtani, Shoichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Absolute lymphocyte count (ALC) as an independent prognostic factor in metastatic breast cancer: a retrospective study
    Sawa, Aya
    Bando, Hiroko
    Kamohara, Reina
    Takeuchi, Naoto
    Terasaki, Azusa
    Okazaki, Mai
    Iguchi-Manaka, Akiko
    Hara, Hisato
    ONCOLOGY, 2022, 100 (11) : 591 - 601
  • [4] Eribulin in Recurrent/Metastatic Breast Cancer (MBC)
    Taha Sethjiwala
    Manikandan Dhanushkodi
    Venkatraman Radhakrishnan
    Jayachandran Perumal Kalaiarasi
    Nikita Mehra
    Archit Joshi
    Arun Kumar Rajan
    Gangothri Selvarajan
    Balasubramanian Ananthi
    Priya Iyer
    Geetha Senguttuvan
    Bharathi Srilatha
    Arvind Krishnamurthy
    Sridevi Velusamy
    Selvaluxmy Ganesarajah
    Trivadi S. Ganesan
    Tenali Gnana Sagar
    Indian Journal of Gynecologic Oncology, 2019, 17
  • [5] Eribulin in Recurrent/Metastatic Breast Cancer (MBC)
    Sethjiwala, Taha
    Dhanushkodi, Manikandan
    Radhakrishnan, Venkatraman
    Kalaiarasi, Jayachandran Perumal
    Mehra, Nikita
    Joshi, Archit
    Rajan, Arun Kumar
    Selvarajan, Gangothri
    Ananthi, Balasubramanian
    Iyer, Priya
    Senguttuvan, Geetha
    Srilatha, Bharathi
    Krishnamurthy, Arvind
    Velusamy, Sridevi
    Ganesarajah, Selvaluxmy
    Ganesan, Trivadi S.
    Sagar, Tenali Gnana
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 17 (03)
  • [6] Utility of Follow-up With Absolute Lymphocyte Count in Patients Undergoing Eribulin Treatment for Early Detection of Progressive Advanced or Metastatic Breast Cancer
    Goto, Wataru
    Kashiwagi, Shinichiro
    Takada, Koji
    Asano, Yuka
    Morisaki, Tamami
    Shibutani, Masatsune
    Tanaka, Hiroaki
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2022, 42 (02) : 939 - 946
  • [7] Interim Absolute Lymphocyte Count (ALC) As a Predictor of Survival in Hodgkin Lymphoma
    Sethi, Tarsheen K.
    Nguyen, Van T.
    Morgan, David S.
    Greer, John P.
    Reddy, Nishitha M.
    BLOOD, 2015, 126 (23)
  • [8] Is there any association between absolute lymphocyte count and increased tumor-infiltrating lymphocytes in metastatic sites in advanced breast cancer patients who get benefit from eribulin treatment?
    Altundag, Kadri
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (03) : 691 - 691
  • [9] Is there any association between absolute lymphocyte count and increased tumor-infiltrating lymphocytes in metastatic sites in advanced breast cancer patients who get benefit from eribulin treatment?
    Kadri Altundag
    Breast Cancer Research and Treatment, 2020, 181 : 691 - 691
  • [10] Monitoring trends in the absolute lymphocyte count and the neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin
    Meng-Xia Su
    Hsiang-Wen Lin
    Hanh T. H. Nguyen
    Tien-Chao Lin
    Chih-Jung Chen
    Hwei-Chung Wang
    Chen-Teng Wu
    Yao-Chung Wu
    Geng-Yan He
    Liang-Chih Liu
    Chih-Hao Huang
    BMC Cancer, 24
12345